DAWN
Price
$8.61
Change
+$0.36 (+4.36%)
Updated
Mar 4, 04:59 PM (EDT)
Capitalization
918.27M
64 days until earnings call
UTHR
Price
$313.13
Change
+$3.09 (+1.00%)
Updated
Mar 4, 11:38 AM (EDT)
Capitalization
14.37B
57 days until earnings call
Ad is loading...

DAWN vs UTHR

Header iconDAWN vs UTHR Comparison
Open Charts DAWN vs UTHRBanner chart's image
Day One Biopharmaceuticals
Price$8.61
Change+$0.36 (+4.36%)
Volume$76.51K
Capitalization918.27M
United Therapeutics
Price$313.13
Change+$3.09 (+1.00%)
Volume$100
Capitalization14.37B
DAWN vs UTHR Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. UTHR commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a StrongBuy and UTHR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (DAWN: $8.25 vs. UTHR: $309.48)
Brand notoriety: DAWN and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 251% vs. UTHR: 150%
Market capitalization -- DAWN: $918.27M vs. UTHR: $14.37B
DAWN [@Biotechnology] is valued at $918.27M. UTHR’s [@Biotechnology] market capitalization is $14.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 4 TA indicator(s) are bullish while UTHR’s TA Score has 4 bullish TA indicator(s).

  • DAWN’s TA Score: 4 bullish, 5 bearish.
  • UTHR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DAWN and UTHR are a bad buy in the short-term.

Price Growth

DAWN (@Biotechnology) experienced а -32.27% price change this week, while UTHR (@Biotechnology) price change was -13.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.55%. For the same industry, the average monthly price growth was -9.46%, and the average quarterly price growth was -5.55%.

Reported Earning Dates

DAWN is expected to report earnings on May 07, 2025.

UTHR is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-3.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($14.4B) has a higher market cap than DAWN($918M). UTHR YTD gains are higher at: -12.289 vs. DAWN (-34.886). UTHR has higher annual earnings (EBITDA): 1.55B vs. DAWN (-210.08M). UTHR has more cash in the bank: 3.33B vs. DAWN (558M). DAWN has less debt than UTHR: DAWN (2.62M) vs UTHR (400M). UTHR has higher revenues than DAWN: UTHR (2.76B) vs DAWN (102M).
DAWNUTHRDAWN / UTHR
Capitalization918M14.4B6%
EBITDA-210.08M1.55B-14%
Gain YTD-34.886-12.289284%
P/E RatioN/A12.99-
Revenue102M2.76B4%
Total Cash558M3.33B17%
Total Debt2.62M400M1%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
12
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNUTHR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMAAX14.93N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
PPQJX3.48N/A
N/A
Principal MidCap Growth III J
FBSIX37.79N/A
N/A
Franklin Mutual U.S. Mid Cap Value R6
ACUIX38.11-0.30
-0.78%
Columbia Dividend Opportunity C
JMVZX32.58-0.36
-1.09%
JPMorgan Mid Cap Value R2

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-8.94%
VCYT - DAWN
43%
Loosely correlated
-3.45%
DNLI - DAWN
42%
Loosely correlated
-8.27%
ACLX - DAWN
41%
Loosely correlated
-3.38%
KROS - DAWN
40%
Loosely correlated
+0.36%
AURA - DAWN
37%
Loosely correlated
-3.74%
More

UTHR and

Correlation & Price change

A.I.dvisor tells us that UTHR and HALO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UTHR and HALO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-3.30%
HALO - UTHR
29%
Poorly correlated
-2.01%
DAWN - UTHR
29%
Poorly correlated
-8.94%
TGTX - UTHR
29%
Poorly correlated
+14.59%
LOGC - UTHR
28%
Poorly correlated
-7.63%
INCY - UTHR
28%
Poorly correlated
-4.29%
More